Evaluación y control de los hipertensos diabéticos atendidos en centros de Atención Primaria de España. Estudio BRAND II

Arauz-Pacheco, 2002, The treatment of hypertension in adult patients with diabetes, Diabetes Care., 25, 134, 10.2337/diacare.25.1.134 Parving, 2002, Controlling hypertension in diabetes, Acta Diabetol., 39, S35, 10.1007/s005920200024 Rodríguez, 1999, Principios de prevención cardiovascular, Med Clin (Barc)., 112, 459 Julius, 2001, Antihypertensive treatment of patients with diabetes and hypertension, Am J Hypertens., 14, 310S, 10.1016/S0895-7061(01)02237-3 UKPDS Group: High Blood Pressure control and risk of macrovascular and microvascular manifestations in type 2 Diabetes (UKPDS 38). BMJ. 1998;317:201–72. Zanchetti, 2002, Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?, J Hypertens., 20, 2099, 10.1097/00004872-200211000-00001 Bakris, 2000, Preserving renal function in adults with hypertension and diabetes: a consensus approach, Am J Kidney Dis., 36, 646, 10.1053/ajkd.2000.16225 Ritz, 2006, Hypertension and antihypertensive treatment of diabetic nephropathy, Nat Clin Pract Nephrol., 2, 562, 10.1038/ncpneph0298 Mancia, 2009, Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document, Blood Press., 18, 308, 10.3109/08037050903450468 Riddle, 2010, Epidemiologic relationships between A1C and all-cause mortality during a median 3. 4-year follow-up of glycemic treatment in the ACCORD trial, Diabetes Care., 33, 983, 10.2337/dc09-1278 Bonds, 2010, The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study, BMJ., 340, b4909, 10.1136/bmj.b4909 Krum, 2010, Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials, Cardiovasc Ther., 28, 124, 10.1111/j.1755-5922.2010.00146.x Darwin, 2004, Metabolic syndrome: Time for action, American Family Physican., 69, 2875 Civeira, 2004, Síndrome metabólico, Medicine., 9, 1131 Costa, 2003, Síndrome metabólico. Resistencia a la Insulina y diabetes. ¿Qué se oculta bajo la punta del iceberg?, Atención Primaria., 31, 436, 10.1016/S0212-6567(03)79204-X Yosefy, 2003, The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality, Prev Med., 37, 571, 10.1016/j.ypmed.2003.09.003 Bestermann, 2004, A systematic approach to managing hypertension and the metabolic syndrome in primary care, South Med J., 97, 932, 10.1097/01.SMJ.0000129923.83896.CC Sowers, 2004, Treatment of hypertension in patients with diabetes, Arch Intern Med., 164, 1850, 10.1001/archinte.164.17.1850 Petrie, 1996, Endothelial nitric oxide production and insulin resistance syndrome, Circulation., 93, 1331, 10.1161/01.CIR.93.7.1331 Hypertension management in adults with diabetes American Diabetes Association Diabetes Care. 2004;27:S65–7. Roberto, 2006, Microalbuminuria in diabetic and hypertensive patients: a study of 979 patients, Med Clin (Barc)., 25, 761 De Pablos-Velasco, 2007, Blood pressure, antihypertensive treatment and factors associated with good blood pressure control in hypertensive diabetics: the Tarmidas study, J Hum Hypertens., 21, 664, 10.1038/sj.jhh.1002214 Álvarez, 2006, Rev Clin Esp., 206, 477, 10.1157/13094895 Dawber, 1980 García, 2003, Control de la presión arterial de los pacientes diabéticos en el ámbito de Atención Primaria. Estudio DIAPA, Med Clin (Barc)., 120, 529, 10.1157/13045871 Barnett, 2004, Angiotensin-receptor blockade versus converting-enzime inhibitionin type 2 diabetes and nephropathy, N Engl J Med., 351, 1952, 10.1056/NEJMoa042274 2001, Selección del tratamiento farmacológico de la hipertensión arterial en Atención Primaria, Med Clin (Barc)., 14, 374 Zanchetti, 2009, Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension, J Hypertens., 27, 673, 10.1097/HJH.0b013e3283298ea2